Member Info for Fastfood

You mean 2.58 Vince ?

Https://m.youtube.com/watch?v=bXNmnu48gf8&feature=youtu.be

Better from AS.

Zeus Capital regularly oversees and advises on corporate takeovers, mergers, and acquisitions (M&A) for its clients.The firm acts as a financial adviser, broker, and Rule 3 Adviser for both the buying and selling sides of transactions.Some prominent takeover transactions Zeus Capital has overseen include:

Sumo Group: Acted as Rule 3 Adviser and Joint Financial Adviser on the £919 million takeover by Tencent Holdings.

OnTheMarket: Advised the company on its £99 million recommended cash offer from CoStar Group.

Moss Bros Group: Advised on the £22.6 million take-private acquisition.

City of London Investment Group: Acted as Financial Adviser on its all-share merger with Karpus Management Inc.

Insig AI: Acted as Nominated Adviser and Sole Broker on the company's reverse takeover and fundraise.

NRG Gyms: Acted as adviser to the buyer on its acquisition of Pump Gyms.

Zeus Capital has completed over 200 transactions with a total gross deal valuation exceeding £17.5 billion.

Key milestone deals for the firm include:

Devolver Digital IPO: Raised $261 million at a $950 million market cap

LBG Media IPO: Handled a £360 million AIM listing in 2021Euromoney Institutional Investor

Assisted Epiris with debt financing for a £1.7 billion take-private

DWF Group IPO: Served as lead manager for the £366 million flotation

Why Zeus is Bigger.

Bigger Deals: Zeus frequently acts as the sole or joint broker for massive IPOs (Initial Public Offerings) and large public company raises. For example, in recent years, they have raised billions for various high-growth companies.

Team Size: With a headcount of nearly 200, Zeus is a mid-sized to large independent corporate finance house. Allenby retains a leaner model of around 35 employees to stay strictly focused on niche micro-cap and small-cap opportunities.

You think a return to 4p is Negative ? You think asking AS to communicate the Company liquidity status for next 12 month and to rule out the need to fundraise is unreasonable ?

Ok … You are all entitled to your opinion I guess…

One thing is certain.

If the Directors ruled out any Fundraise / then SP would shoot back up to 4p.

But they absolutely won’t do this. Such is the messy Navigation of the Corporate World.

Us Private Investors mean Nothing to them. Less than Nothing.

I’m completely with Techtonic with this. Smells of a fundraiser. SP 3.8 smashed down to 2.5 on great news. Appoint Broker. No cash in the Bank. Where’s the TR-1 ? If it comes through super late (We are in that Territory now) then we e all took one for the Team.

And if the Directors are going to realise the second milestone at 5p / along with their beyond 2p growth CLIA milestone then those Shares are going to have to land in someone else’s hands….. Eventually.

Doubt it. Just a way of expanding the footprint evidenced by historical nil volume.

Agreed Owl.

At some point the Value re £750m Annual Share buyback vs increasing the dividend will start to shift.

If Tesco diverted all of the £750m to dividend on a 6.2b Share count / then that would allow 12% on top of current 4% dividend.

Now I’m not saying Shareholders will see that 12% but there is certainly headroom for future dividend appreciation, whilst at the same time reducing debt on the balance sheet.

No wonder Deutsche Bank go £5.25. And then some…

Kaboom !!!

May 2022 Following the purchase of these shares, the remaining number of ordinary shares in issue will be 7,512,461,165. The Company does not hold any ordinary shares in Treasury.

4 years on the Share count has for the first time gone below 6,300,000,000

How’s the China deal going Allan ? Over 4 years now in the making.

If no news on that / then please inform us what the Expectations are and what Success may look like re next 18 month US Rollout. Let’s have some feedback on initial Sales and later some Testimonials on how the Ciz1b Test is changing lives over the pond.

Thank you.

Test.

5p £25million

10p £50million

15p £75million

Any of these out of the Question ??

See bottom line.

In the UK, the taxation process typically involves the following stages:1. When you get the options (Grant Date)You usually do not pay tax when the company first offers you the share options.2. When you buy the shares (Exercise Date)When you use your options to buy shares, this is called "exercising" the option. At this point, you generally must pay Income Tax and National Insurance on the difference between what you paid for the shares (the strike price) and what they are actually worth at that time.3. When you sell the shares (Sale Date)When you sell the shares later, you may have to pay Capital Gains Tax (CGT) if the shares have increased in value since you bought them.Tax-Advantaged SchemesDirectors can pay much less tax if their company uses specific government-approved schemes:Enterprise Management Incentives (EMI): Available for qualifying smaller companies. If you meet the rules, you usually pay no Income Tax or National Insurance when you exercise the options.Company Share Option Plan (CSOP): Allows up to \(\pounds60,000\) in shares. If you hold the options for at least three years, you do not pay Income Tax or National Insurance when you exercise them.

23-Jun-26 Deutsche old 500.00 new 525.00 Reiteration Buy.

Bodes well next 12 Month. I have found in past that Deutsche Bank (Not easy to spell) are fairly accurate with their 12 month SP predictions and they tend not to exaggerate.

Also / aggressive 6m Shares buyback yesterday. This second Tranche won’t last long at that rate from Santander. £4:40 seems to be the new bottom then.

GLA.

No PR all Top Secret.

Why don’t the 3 Directors put us all out of our Misery and just cash in those 2p Options ?

Upon reflection maybe they have already and RNS delayed ?

A Positive sign if they do not cash in until higher SP, BUT how would the Market cope with those CLIA 2p Options at 4p / 6p etc. Hence we see a Depressed SP currently.

Are those First tranche Options acting as a suppressant until further Progress re NHS and data on US sales is communicated to the Market ?

Where’s the TR-1 ????? !!!!! …..